Presentation of narcolepsy after 40

Neurology

Volumn 50, Issue 2, 1998, Pages 459-465

  Rye, D B ^a,d   Dihenia, B ^b   Weissman, J D ^c   Epstein, C M ^d   Bliwise, D L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c Neurol Res and Education Center   (United States)

^d Georgia Baptist Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; CLINICAL EXAMINATION; FEMALE; HUMAN; MALE; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; RETROSPECTIVE STUDY; SOMNOLENCE;

EID: 0031935227     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.2.459     Document Type: Article

References (45)

1. Guilleminault C. Primary disorders of daytime somnolence. In: Kryger M, Roth T, Dement W, eds. Principles and practice of sleep medicine. 2nd ed. Philadelphia, PA: W.B. Saunders, 1994:549-561.
2. Honda Y, Asaka A, Tanimura M, Furusho T. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York, NY: Raven Press, 1983:188-199.
3. Rechtschaffen A, Wolpert E, Dement W. Nocturnal sleep of narcoleptics. Electroencephalogr Clin Neurophysiol 1963;15: 599-609.
4. Schenck C, Mahowald M. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol 1992;32:3-10.
5. Mignot E, Tafti M, Dement W, Grumet F. Narcolepsy and immunity. Adv Neuroimmunol 1995;5:23-37.
6. Hublin C, Partinen M, Kaprio J, Koskenvuo M, Guilleminault C. Epidemiology of narcolepsy. Sleep 1994;17:S7-S12.
7. Thorpy M, Committee DCS. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990.
8. Poirier G, Montplaisir J, Dumont M, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987;37:693-695.
9. Park J, Radtke R. Hypersomnolence in myotonic dystrophy: demonstration of sleep onset REM sleep. J Neurol Neurosurg Psychiatry 1995;58:512-513.
10. Maccario M, Ruggles K, Meriwether M. Post-traumatic narcolepsy. Mil Med 1987;152:370-371.
11. Reynolds CF, Coble PA, Kupfer DJ, Holzer BC. Application of the Multiple Sleep Latency Test in disorders of excessive sleepiness. Electroencephalogr Clin Neurophysiol 1982;53: 443-452.
12. Walsh J, Smitson S, Kramer M. Sleep-onset REM sleep: comparison of narcoleptic and obstructive sleep apnea patients. Clin Electroencephalogr 1982;13:57-60.
13. Moscovitch A, Partinen M, Guilleminault C. The positive diagnosis of narcolepsy and narcolepsy borderland. Neurology 1993;43:55-60.
14. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996;46:393-401.
15. Baker T, Guilleminault C, Nino-Murcia G, Dement W. Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep 1986;9:232-242.
16. Guilleminault C. Sleeping and waking disorders: indications and techniques. Menlo Park, CA: Addison-Wesley, 1982.
17. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: U.S. Government Printing Office, 1968.
18. Guilleminault C, Bonnet M, Carley D, et al. Recording and scoring leg movements. Sleep 1993;16:749-59.
19. Guilleminault C, Bonnet M, Carley D, et al. EEG arousals: scoring rules and examples. Sleep 1992;15:173-184.
20. Carskadon M. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-524.
21. Park M, Tonai R. Phenotype frequencies of the class II (DR, DQ) DNA alleles by patterns of sequence-specific primer mixtures (SSPM) in four different populations and the probable haplotypes between DRB1 allele and DQB1 allele. In: Terasaki P, Cecka M, eds. Clinical transplants 1992. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1992:475-500.
22. Terasaki P, Bercnoco D, Park M, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A,-B, -C, and -D antigens. Am J Clin Pathol 1978;69:103-120.
23. Fogdell A, Hillert J, Sachs C, Olerup O. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995;46:333-336.
24. Yoss R, Daly D. Narcolepsy. Med Clin North Am 1960;44:953-968.
25. Aldrich M. Narcolepsy. Neurology 1992;42:34-43.
26. Sours J. Narcolepsy and other disturbances in the sleepwaking rhythm: a study of 115 cases with review of the literature. J Nerv Ment Dis 1963;137:525-542.
27. Kales A, Cadieux R, Soldâtes C, et al. Narcolepsy-cataplexy I. Clinical and electrophysiologic characteristics. Arch Neurol 1982;39:164-168.
28. Billiard M, Besset A, Cadilhe J. The clinical and polygraphic development of narcolepsy. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York, NY: Raven Press, 1983:187-199
29. Zarcone V. Narcolepsy. N Engl J Med 1973;31:1156-1166.
30. Roth T, Merlotti M. Advances in the diagnosis of narcolepsy. The Third International Symposium on Narcolepsy. Oak Park, IL: Association Plus, 1985:3-6.
31. Rosenthal LD, Zorick FJ, Merlotti L, Wittig RIM, Roehrs TA, Roth T. Signs and symptoms associated with cataplexy in narcolepsy patients. Biol Psychiatry 1990;27:1057-1060.
32. Guilleminault C, Mignot E, Partinen M. Controversies in the diagnosis of narcolepsy. Sleep 1994;17:S1-S6.
33. Jackson C, Bachman D. Narcolepsy-related psychosis misinterpreted as schizophrenia. Neuropsychiatr Neuropsychol Behav Neurol 1996;9:139-140.
34. Chokroverty S. Sleep apnea in narcolepsy. Sleep 1986;9:250-253.
35. Guilleminault C, Philip P. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 1996;19:S117-S122.
36. Lamphere J, Young D, Roehrs T, Wittig R, Zorick F, Roth T. Fragmented sleep, daytime somnolence and age in narcolepsy. Clin Electroencephalogr 1989;20:49-54.
37. Aldrich MS. 700,000 miles of crash-free automobile driving by an undiagnosed untreated narcoleptic. Sleep Research 1995; 24:185. Abstract.
38. Broughton W, Broughton R. Psychosocial impact of narcolepsy. Sleep 1994;17:S45-S49.
39. Billiard M, Scignalet J, Basset A, Cadihac J. Narcolepsy without cataplexy: a clinical variant. Sleep Research 1987;16:308. Abstract.
40. Honda Y, Juji T, Matsuki K, et al. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 1986;9:133-142.
41. Hayduk R, Flodman P, Spence M, Erman M, Miller M. Monozygotic twins with narcolepsy: preliminary report. Sleep Research 1996;25:252. Abstract.
42. Mignot E, Kimura A, Lin X, Grumet F, Guilleminault C, Dement W. HLA studies in forty-seven non DR15 (DR2) narcoleptic patients. Sleep Research 1996;25:302. Abstract.
43. Mignot E, Meehan J, Grumet F, et al. HLA class II and narcolepsy in thirty-three multiplex families. Sleep Research 1996;25:303. Abstract.
44. Aldrich M, Rogers A. Exacerbation of human cataplexy by prazosin. Sleep 1989;12:254-256.
45. Mignot E, Guilleminault C, Bowersox S, et al. Effect of alpha 1-adrenoceptor blockade with prazosin in canine narcolepsy. Brain Res 1988;444:184-188.